drugset / Trial / NCT07055958

Effect of Metformin as Add-on Therapy in Levodopa Treated Parkinson's Disease Patients

NCT07055958 ↗

Phase 3 Active not recruiting 74 enrolled Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this clinical trial is to learn that metformin has effect on motor aspects of daily living and oxidative stress in levodopa treated Parkinson disease patients. Researcher will compare drug metformin to a placebo. Participants will take metformin or placebo for 8 weeks.

Timeline

Start
2024-12-29
Primary completion
2025-06-30
Completion
2025-07-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg —

Indications